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BACKGROUND: The persistence of depressive symptoms after hospital-
ization is a strong risk factor for mortality after acute coronary syn-
dromes (ACS). Poor adherence to secondary prevention behaviors
may be a mediator of the relationship between depression and increased
mortality.
OBJECTIVE: To determine whether rates of adherence to risk reducing
behaviors were affected by depressive status during hospitalization and
3 months later.
DESIGN: Prospective observational cohort study.
SETTING: Three university hospitals.
PARTICIPANTS: Five hundred and sixty patients were enrolled within
7 days after ACS. Of these, 492 (88%) patients completed 3-month
follow-up.
MEASUREMENTS: We used the Beck Depression Inventory (BDI) to
assess depressive symptoms in the hospital and 3 months after dis-
charge. We assessed adherence to 5 risk-reducing behaviors by patient
self-report at 3 months. We used w2 analysis to compare differences
in adherence among 3 groups: persistently nondepressed (BDI o10 at
hospitalization and 3 months); remittent depressed (BDI 10 at hos-
pitalization; o10 at 3 months); and persistently depressed patients
(BDI 10 at hospitalization and 3 months).
RESULTS: Compared with persistently nondepressed, persistently de-
pressed patients reported lower rates of adherence to quitting smoking
(adjusted odds ratio [OR] 0.23, 95% confidence interval [95% CI] 0.05 to
0.97), taking medications (adjusted OR 0.50, 95% CI 0.27 to 0.95),
exercising (adjusted OR 0.57, 95% CI 0.34 to 0.95), and attending
cardiac rehabilitation (adjusted OR 0.5, 95% CI 0.27 to 0.91). There
were no significant differences between remittent depressed and
persistently nondepressed patients.
CONCLUSIONS: Persistently depressed patients were less likely to
adhere to behaviors that reduce the risk of recurrent ACS. Differences
in adherence to these behaviors may explain in part why depression
predicts mortality after ACS.
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D epressive symptoms are common after acute coronarysyndromes (ACS) and occur in as many as 45% of pa-
tients during hospitalization with ACS.1 Depressive symptoms
at the time of hospitalization are an independent risk factor
for mortality after ACS.2–5 According to a recent meta-analysis
of 7 prospective studies, depressive symptoms carry a mortal-
ity hazard ratio of 1.76 among patients with coronary artery
disease after adjusting for other known risk factors.6 These
findings place depression on par with other, more classic
cardiac risk factors, such as high cholesterol level or hyper-
tension.7,8
Depressive symptoms are associated with decreased ad-
herence to recommended risk-reducing behaviors for a range
of chronic illnesses, including diabetes, human immuno-
deficiency virus infection, and hypertension.9–15 Depressive
symptoms have been associated with decreased adherence
in those with coronary artery disease with respect to taking
medications, attending cardiac rehabilitation, quitting
smoking, exercising, and modifying diet.16–20 Prior research
has shown that depressive symptoms immediately following
myocardial infarction (MI) predict poor self-reported adher-
ence to recommended behaviors 4 months after ACS.21
Poor adherence to these recommended behaviors has
been proposed as a potential mediator of the relationship
between depression and increased mortality in patients after
ACS.22,23
Although depressive symptoms are common in the days
following an ACS, these symptoms do not persist in all pa-
tients.1,24 In 1 study, up to 70% of patients remain persistently
depressed 1 month after a MI.25 Depressive symptoms at the
time of hospitalization may be the expression of an acute
stress reaction to the cardiac event and may resolve upon
returning home. However, a subset of patients remains per-
sistently depressed after discharge from the hospital. Patients
in this subset may be at higher risk for recurrent ACS than
patients whose depressive symptoms remit.26 Few studies
have examined the degree to which depressive symptoms
persist after ACS and, to our knowledge, no studies have as-
sessed the relationship between persistence of depression and
adherence to risk reducing behaviors.27 In order to better iden-
tify patients at risk for poor adherence, it is important to know
whether the persistence of depressive symptoms is related to
adherence.
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We hypothesized that persistently depressed patients
would have lower reported rates of adherence to recommend-
ed behaviors for prevention of recurrent ACS than persis-
tently nondepressed patients in the 3 months after ACS.
In addition, we tested whether adherence to recommended
behaviors differed between persistently depressed patients




This was a substudy of the Coronary Psychosocial Evaluation
Study (COPES), a multicenter prospective observational cohort
study that examines the role of psychosocial factors in the as-
sociation of depression with ACS prognosis. Patients were en-
rolled from coronary care and cardiac step-down units of 3
university hospitals (Mount Sinai Hospital; University of Med-
icine and Dentistry of New Jersey, Newark, NJ; and Yale–New
Haven Hospital, New Haven, CT) between May 1, 2003 and
April 15, 2005. Patients who were at least 18 years of age and
were admitted with a diagnosis of acute MI or unstable angina
were asked to participate. This study was approved by the In-
stitutional Review Boards of the 3 sites.
Criteria for acute ST-segment elevation MI were the pres-
ence of ischemic chest pain lasting more than 20 minutes and
ST-segment elevation of more than 1mm in at least 2 contig-
uous leads of the electrocardiogram. Unstable angina and
non–ST-segment elevation MI were defined as 1 or more symp-
toms from the following list: new-onset angina within 2
months, exacerbations of previous angina with pain at rest
or with minimal exercise, prolonged chest pain lasting more
than 20 minutes, or angina within 2 weeks following discharge
for MI. In addition, patients with unstable angina or non–ST-
segment elevation MI had to have at least 1 of the following
criteria: ischemic electrocardiographic changes, angiogram
positive for coronary artery disease (CAD) on current admis-
sion, documented history of CAD, or acute rise in serum car-
diac enzymes.
Patients were eligible for inclusion if they had no terminal
illness, no major deficits in cognition and no active substance
abuse, if the interviews could be completed within 7 days of the
initial hospitalization date, and if follow-up availability could
be expected. In addition, patients had to have a total score on
the Beck Depression Inventory (BDI) ofo5 or4 9. The BDI is a
validated self-report instrument that has been used in previ-
ous studies of depression and ACS.28 Using a cutoff score of
10, the BDI has a sensitivity of 82% and specificity of 79% for
diagnosing major depression in patients diagnosed with MI.29
A score of 0 to 4 is consistent with a low-normal level of
depressive symptoms and has not been associated with
any increased risk for ACS recurrence. A BDI score of 5 to
9 is consistent with a high-normal level of depressive
symptoms, and a BDI score of greater than 9 represents at
least mild to moderate depression and has been validated as a
score predictive of increased post-ACS mortality.4,26 We
excluded patients with BDI scores of 5 to 9 to clearly delin-
eate groups of patients who were depressed and nondepressed
at baseline. Clinicians were not made aware of BDI results
as part of this study. The assembly of the cohort is shown in
Figure 1.
Assessment of Baseline Characteristics and
Depression Status
Baseline demographic and clinical variables, including the
Charlson comorbidity index, were obtained at the time of en-
rollment by patient interview and chart abstraction. The
Charlson index has been validated as a measure of risk for
death in patients with chronic illness.30 The BDI was initially
administered to assess symptoms of depression within 7 days
of the ACS; the BDI was again administered after 3 months.
Assessment of Adherence
At 3months, patients were also asked about their adherence to
behaviors likely to be beneficial in reducing their risk for a
subsequent coronary event.31 These questions included ask-
ing whether they had (1) smoked tobacco products in the last 7
days; (2) participated in a cardiac rehabilitation program; (3)
exercised regularly; and (4) modified their diet to be heart
healthy. Patients who reported smoking at baseline but not
at 3 months were categorized as having quit smoking. Patients
did not receive any specific counseling regarding these behav-
iors as part of the study.
In addition, patients were asked about their medication
adherence using amodifiedMorisky scale.32 TheMorisky scale
is an adherence screening tool that has been validated to pre-
dict whether patients adhere to their medications. TheMorisky
score is calculated by assigning 1 point for each positive an-
swer and summing them to obtain a total score between 0 and
4. Patients with a score from 0 to 1 were categorized as
having good medication adherence, whereas patients with a
score from 2 to 4 were categorized as having poor medication
adherence.32
Statistical Analysis
We used w2 analysis to determine whether there were statisti-
cally significant differences for self-reported adherence for (1)
persistently depressed (BDI 10 at hospitalization and 3
months), compared with persistently nondepressed (BDI
o10 at hospitalization and 3 months) and remittent depressed
(BDI 10 at hospitalization; o10 at 3 months) and (2) remit-
tent depressed compared with persistently nondepressed
patients. Only 16 patients completing follow-up became new-
ly depressed at 3 months. These patients were excluded in
further statistical analyses.
Multivariate logistic regression was used to calculate ad-
justed odds ratios (ORs) and 95% confidence intervals (CIs)
controlling simultaneously for prespecified confounders. So-
ciodemographic variables that had a significant univariate as-
sociation with any single adherence outcome at a level of
Po.10 were included in the multivariate model. Partner sta-
tus and years of education were not included as these were
collinear with whether patient lived alone and employment
status, respectively. We used the Charlson index as a summa-
ry index of comorbidity. We tested analyses using individual
comorbidities that had an association with either the exposure
or the outcome of interest, but none changed the estimate and
hence were not included in the final model. Analyses were
performed using SPSS statistical software (version 13.0;
SPSS Inc., Chicago, IL).
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RESULTS
Characteristics
Five thousand six hundred and ninety-two patient charts
were screened (Fig. 1). Of these potentially eligible patients,
741 (13.0%) were not included in the study because of physi-
cian or patient refusal. These patients differed significantly
from patients that participated in the study: refusers were
more likely to be Hispanic (24.3% vs 12.5%, respectively,
P=.01) and older (mean age 65.2 [SD 11.9] years vs 61.5 [SD
12.2] years, respectively, Po.001) than participants. We
found that patients who were lost to follow-up were more like-
ly to have diabetes, prior congestive heart failure, higher mean
Charlson score, and a lower number of years of education
(Po.05). Fifteen patients died during the follow-up period.
When deceased patients were excluded from the group
without follow-up, we found that there were no significant
differences between patients who did and did not complete
follow-up.
The characteristics of the study population according to
depression status are summarized in Table 1. The mean (SD)
age of the cohort was 60.6 (12.2) years. Forty-one percent of
patients were women, 11% were Hispanic, and 13% were
black. The mean (SD) BDI score for patients at the time of hos-
pitalization was 8.5 (8.6). At 3-month follow-up, the mean BDI
score was 6.8 (8.1).
Compared with persistently nondepressed patients, persist-
ently depressed patients were more likely to be young, female,
Hispanic, without a spouse or partner, unemployed, and less
educated (Po.05). Compared with persistently nondepressed
patients, persistently depressed patients also had a higher co-
morbidity burden in terms of Charlson score, presence of di-
abetes mellitus, hypercholesterolemia, prior MI, and prior
congestive heart failure. Compared with persistently nonde-
pressed patients, remittent depressed patients were more like-
ly to be young, female, Hispanic, without a spouse or partner,
living alone, and less educated (Po.05). Remittent depressed
patients did not differ from persistently nondepressed patients
in Charlson score or other disease variables.
Self-reported Adherence Behaviors at 3 Months
Patients’ reported adherence to recommended behaviors after
ACS according to their depression status are shown in Table 2.
Persistently depressed patients were less likely than patients
who were never depressed to report quitting smoking, taking
medications regularly, exercising, and attending a cardiac re-
habilitation program (Po.05). Adherence did not significantly
differ between patients whose symptoms of depression remit-
ted and those who were never depressed. The 3 groups did




5132 Excluded  
2147 Did not meet inclusion criteria for Acute 
Coronary Syndrome     
1450 Logistic Reasons (inaccessible for follow-  
up; language barrier; screened more than 7
days after ACS; unable to complete
enrollment within 7 days of ACS) 
549 Medical Reasons (life threatening  
condition; major psychological comorbidity;
cognitive impairment) 
245 Beck Depression Inventory score 5-9 
179 Physician refusal 
571 Participant refusal 
492 Completed 3-Month Follow-Up
68 No 3-month Follow-up  
   15 Deceased 
   30 Missed 3-month visit 
   21 Dropped-out of study  
2 Missing 3-month BDI  
Depressed  
Baseline BDI≥10 
n = 220 
Not depressed  
Baseline BDI 0-4 















n = 256  n = 16   
FIGURE 1. Study flowchart. ACS, acute coronary syndrome; BDI, Beck Depression Inventory.
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Multivariable Model
We used logistic regression to determine unadjusted and ad-
justed odds of adhering to recommended behaviors by depres-
sion status (Table 2). In both the adjusted and unadjusted
models, persistently depressed patients were more at risk of
not adhering to recommended behaviors for all but one cate-
gory (modified diet) as compared with persistently nonde-
pressed patients, and adjusted ORs ranged from 0.23 to
0.57. In contrast, the adherence behaviors of remittent de-
pressed patients were not significantly different than the ad-
herence behaviors of persistently nondepressed patients.
DISCUSSION
In this multicenter observational cohort study of patients after
ACS, we found that patients whose symptoms of depression
persisted after hospitalization were at higher risk for not ad-
hering to recommended preventive behaviors, including quit-
ting smoking, exercising, attending cardiac rehabilitation, and
taking medications regularly. Furthermore, we found that
there were no statistically significant differences in adherence
between patients whose symptoms of depression remitted and
patients who were never depressed.
Depression is associated with poor motivation, low self-
esteem, and low energy, characteristics that may be necessary
for the maintenance of healthy behaviors and lifestyle chang-
es. While it is possible that depressed patients are informed
differently than nondepressed patients about the importance
of secondary prevention behaviors, in our study it is unlikely
that persistently depressed patients would have been informed
differently than the remittent depressed group as they both
started out depressed in hospital. Assuming that both remit-
tent depressed and persistently depressed patients received
equal advice from their health care providers about secondary
prevention, then the lower rate of engagement in these
activities by persistently depressed patients is more likely due
to the effect of the persistent depressive symptoms on patients’
ability to adhere to recommended behaviors.
This evidence confirms and extends previous findings
that have shown that depression is a risk factor for poor ad-
herence after ACS. Whereas previous authors have noted that
depression at hospitalization is a risk factor for poor adher-
ence 4 months later, we have shown that it is the persistence of
depression that may confer this risk of poor adherence as there
were no significant differences in adherence among those
whose depressive symptoms remitted and those who were
never depressed.21
In addition to incorporating repeated measures of de-
pressive symptoms, another strength of our study is the
diversity in the patient sample in terms of sex, race, and
ethnicity, as well as the enrollment of patients from multiple
hospital sites. Although there were significant differences in
the socioeconomic status of our patients when analyzed by
depression status, the association between depression status
and adherence remained robust when we accounted for these
variables.
There were several limitations of this study. First, we had
a moderate rate of refusal to participate in the study among
potentially eligible subjects. Patients who refuse to participate
in research studies might have poorer adherence. As a result,
our findings may overestimate the true rates of adherence to
secondary prevention behaviors among post-ACS patients.
Second, we may not have been able to account for all possible
confounders. For example, we were not able to adjust for the
number of medications prescribed, which some research has
shown is associated with adherence.33 Similarly, some studies
have shown that income correlates with poor adherence; we
used employment status as a surrogate marker for income.
Third, we were unable to account for the effect that identifica-
tion and treatment of depressive symptoms by providers may
have had on adherence. Providers, however, were not made












Mean (SD) age, y 60.6 (12.2) 62.4 (11.5) 59.8 (12.4) 57.2 (12.8) .001
Mean (SD) years of education 13.9 (3.2) 14.6 (3.0) 13.8 (3.0) 12.6 (3.3) o.001
Female 202 (41.1) 91 (35.5) 53 (47.3) 53 (49.1) .02
Hispanic 44 (8.9) 8 (3.1) 15 (13.4) 20 (18.5) o.001
Black 58 (11.8) 25 (9.8) 13 (11.6) 16 (14.8) .38
Lives alone 106 (21.8) 44 (17.3) 34 (30.9) 23 (21.7) .02
Married/partner 318 (64.6) 183 (71.5) 67 (59.8) 60 (55.6) .006
Employed 248 (51.3) 139 (55.2) 55 (50.0) 44 (41.9) .07
Clinical
Smoked at baseline 88 (17.9) 35 (13.7) 24 (21.4) 23 (21.3) .09
Hypertension 327 (67.1) 165 (65.2) 72 (64.9) 78 (72.9) .32
Diabetes mellitus 144 (29.6) 62 (24.4) 35 (31.3) 42 (40.4) .01
Hypercholesterolemia 330 (69.9) 158 (64.2) 79 (73.1) 81 (79.4) .01
Prior myocardial infarction 115 (24.8) 46 (19.1) 30 (28.6) 34 (33.7) .01
Prior congestive heart failure 31 (6.4) 12 (4.7) 5 (4.6) 14 (13.2) .008
Mean (SD) Charlson index 1.3 (1.5) 1.1 (1.3) 1.3 (1.5) 1.7 (1.7) o.001
Mean (SD) BDI score, baseline 8.5 (8.6) 2.0 (1.4) 14.0 (4.2) 19.1 (8.1) o.001
Mean (SD) BDI score, 3mo
follow-up
6.8 (8.1) 2.1 (2.3) 5.1 (2.7) 18.8 (8.4) o.001
Data are presented as number (%) of patients unless indicated otherwise. Denominators for variables vary slightly due to missing responses. Less than
5% of responses were missing.
wP-value refers to overall comparisons between persistently nondepressed, remittent depressed, and persistently depressed groups. Dichotomous
variables were compared using w2 statistics and continuous variables using 1-way ANOVA.
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aware of BDI results from the study. Finally, information per-
taining to adherence behaviors was primarily derived from
self-report. It is possible that patients who have experienced
ACS may adhere to recommended behaviors at similar levels
but only report differently according to the influence of their
depressive symptoms. According to some psychological stud-
ies, depressed patients may be more likely to accurately report
maladaptive behaviors than their nondepressed counter-
parts.34,35
Our study corroborates prior research that has shown
poor overall rates of adherence to healthy lifestyles after
ACS.36,37 Previous studies have shown that poor adherence
is associated with poorer outcomes after ACS.38 For example,
in the Beta Blocker Heart Attack Trial, patients who did not
adhere to the study medication after MI, whether or not the
medication was placebo, were 2.6 times more likely to die
within 1 year.39 This finding is consistent with the hypothesis
that decreased adherence to healthy secondary prevention
behaviors may be a mediator in the association of depression
and mortality after ACS.
Researchers are beginning to study the effectiveness of
screening for and addressing poor adherence among patients
with chronic illnesses such as diabetes mellitus and heart dis-
ease.40 In some populations, such as patients with human
immunodeficiency virus infection and diabetes mellitus, treat-
ment of depression has been to shown to improve adher-
ence.41,42 Among patients with diabetes mellitus, some trials
have shown that enhanced treatment of depression can lead
to improvements not only in adherence, but also in diabetic
outcomes.43 Accordingly, the American Diabetes Association
has added screening for mood disorders to its guidelines for
standard diabetic assessments.44
Two major randomized control trials of post-ACS pa-
tients have failed to demonstrate that enhanced depression
treatment can improve post-ACS outcomes.45,46 None of these
trials specifically attempted to impact the adherence of pa-
tients. Future studies should assess whether enhanced
screening and treatment of depressive symptoms can improve
adherence in patients after ACS and whether improved adher-
ence, in turn, can improve post-ACS mortality. These studies
should also assess whether the BDI is an optimal tool for di-
agnosing depression in the post-ACS setting. Our study sug-
gests that among patients who have experienced ACS,
resources for screening and treating depression may be best
directed at patients who are depressed at follow-up, not only in
the hospital. In addition, our study suggests that it may be
important to include adherence counseling as part of depres-
sion treatment programs in post-ACS patients.47
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